cemiplimab-rwlc
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cemiplimab-rwlc, covering 2022-07-14 to 2022-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC [Phase 2]